These success, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the notion of concentrating on ACKR3 as a unique technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. By ticking this box https://kingj147nkg6.blogitright.com/profile